glp 1 and inflammation reduction Bridging the gap between GLP1-receptor agonists cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology The anti-inflammatory and immunological properties

The microdosing trend with GLP-1 medications reveals something we see constantly in women's health: patients innovating faster than the research can keep up

Does ColonBroom GLP-1 work or fall short

Hosted by obesity rights advocate advocate Amanda Bonello, the GLP-1 Studio Podcast is where science, lived experience, and a little bit of I cannot believe we have to fight this hard for healthcare energy all come together

In this paper we will explore the current state of play, suggest a possible future path for global sugar consumption and highlight ways companies can adapt so they can benefit from GLP-1 receptor agonists disruption.

Learn how Aetna can support your benefit strategy and your employees health goals.

Experts have some real concerns.